BANK VONTOBEL/CALL/STRYKER CORP./330/0.1/21.06.24 Stock

Warrant

DE000VM576T9

Market Closed - Boerse Frankfurt Warrants 02:03:20 2024-06-07 pm EDT
2 EUR +11.11% Intraday chart for BANK VONTOBEL/CALL/STRYKER CORP./330/0.1/21.06.24
Current month+53.85%
1 month+110.53%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-07 2 +11.11%
24-06-06 1.8 +6.51%
24-06-05 1.69 +15.75%
24-06-04 1.46 +17.74%
24-06-03 1.24 -4.62%

Real-time Boerse Frankfurt Warrants

Last update June 07, 2024 at 02:03 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM576T
ISINDE000VM576T9
Date issued 2023-11-30
Strike 330 $
Maturity 2024-06-21 (12 Days)
Parity 10 : 1
Emission price 5.38
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.53
Lowest since issue 0.51
Spread 0.03
Spread %1.47%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
349.3 USD
Average target price
373.1 USD
Spread / Average Target
+6.80%
Consensus